TXNIP and metabolic dysfunction-associated steatohepatitis: Islam N Mohamed et al. also reported that Txnip deletion ameliorates HFD-induced steatosis, inflammatory and fibrotic response, suggesting a pathogenic role of TXNIP in NASH 30.